Secret drug pricing deals, a virtual AI cancer clinic, and other biotech news from The Readout
Manuel Balce Ceneta/AP
By Meghana Keshavan
May 7, 2026
Biotech Correspondent
Meghana Keshavan
RevMed's cancer drug feels out of reach for some, SCOTUS preserves key generic drug pathway, and more biotech news
Alzheimer's drug rollout letdown, a China-based heart drug startup, and more biotech news from The Readout
The companies developing Ebvallo reached an agreement with the FDA to address its main reason for rejecting the drug.
Revolution and Tango yield promising cancer results, Incyte buys bleeding disorder drug, and more biotech news
Even as a new drug pricing specter rears its head in President Donald Trump’s “Most Favored Nation” policies, drugmakers continue…
The FDA's new path, the status of animal testing, and other biotech news from The Readout
